Navigation Links
Financial in Biological Technology
SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
BOTHELL, Wash., Aug. 7 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE Amex: DDD ) today reported financial results for the three and six months ended June 30, 2009. Dr. Bruce Morra, SCOLR Pharma's President and CEO, said, "We continue to advance discussions with a number o...Novavax Reports Second Quarter 2009 Financial Results
ROCKVILLE, Md., Aug. 7 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today reported a net loss of $8.5 million, or $0.10 per share, for the second quarter of 2009 compared to a net loss of $9.4 million, or $0.15 per share, for the second quarter of 2008. For the six month...Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
CORAL GABLES, Fla., Aug. 7 /PRNewswire-FirstCall/ -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today reported financial results for the second quarter and six months ended June 30, 2009. Second Quarter 2009 Results For the quarter ended June 30, 2009, th...American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
NEW YORK, Aug. 7 /PRNewswire-Asia-FirstCall/ -- --2Q09 Revenue Increased 20.7% YoY to $71.2 Million-- --2Q09 Net Income Attributable to Controlling Interest was $13.2 million or $0.17 per Diluted Share-- -- Company Generates Approximately $...AutoImmune Inc. Reports 2009 Second Quarter Financial Results
PASADENA, Calif., Aug. 6 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Bulletin Board: AIMM) today reported a net loss of $86,000, or $0.01 per share basic and diluted, for the three months ended June 30, 2009, compared with a net loss of $86,000, or $0.01 per share basic and diluted, for th...GenVec Reports Second Quarter 2009 Financial Results
GAITHERSBURG, Md., Aug. 6 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today announced its financial results for the second quarter ended June 30, 2009. (Logo: http://www.newscom.com/cgi-bin/prnh/20081205/DC50112LOGO ) GenVec reported a net loss of $4.8 milli...Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release r...ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today the appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and treasurer. Mr. Driscoll will report to Dr. Rahul Singhvi, Novavax's President and Chief Executive Officer. ...
NEWTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Microfluidics International Corporation (OTC Bulletin Board: MFLU) announced today that the Company will release second quarter 2009 financial results on Tuesday, August 11, 2009, before the opening of the U.S. financial markets. Mi...
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
BRISBANE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced results from operations for the second quarter and six months ended June 30, 2009. InterMune reported a net loss for the second quarter of 2009 of $36.7 million, or $0.81 per shar...SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
SAN DIEGO, Aug. 6 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM ), today reported its financial results for the quarter ended June 30, 2009. (Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO ) Second Quarter Results Total revenue fo...OncoGenex Reports Second Quarter 2009 Financial Results
Conference Call on Thursday, August 6, 2009 at 4:30 p.m. Eastern Time BOTHELL, WA, and VANCOUVER, Aug. 6 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ) today reported unaudited financial results for the second quarter and six mo...Telik Announces Second Quarter 2009 Financial Results
PALO ALTO, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK ) today reported a net loss of $5.7 million, or $0.11 per share, for the second quarter ended June 30, 2009, compared with a net loss of $13.6 million, or $0.26 per share, for the comparable period in 2008. ...REYKJAVIK, Iceland, August 6 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (Nasdaq: DCGN ) today announced that it will report its second quarter 2009 financial results in a press release to be issued on Monday, August 10, after the close of the market in New York. The company will host a ...
Oncothyreon announces webcast of second quarter 2009 financial results conference call
SEATTLE, Aug. 6 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it intends to release its second quarter and year end 2009 financial r...VANCOUVER, Aug. 6 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced its financial results for the second quarter ended June 30, 2009. "We were pleased to observe continued sales growth in our Proprietary Medical Products business during the quar...
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today reported results for the first quarter fiscal year 2010, ended June 30, 2009. Total revenue for the quarter was $5,061,000 compared to total revenue of $13,660,000 for the first quarter of fiscal ye...Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
NEW YORK, Aug. 5 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, includin...PDI Reports 2009 Second Quarter Financial Results
SADDLE RIVER, N.J., Aug. 5 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII ), a leading provider of sales and marketing support to U.S. pharmaceutical companies, today reported financial and operational results for the second quarter ended June 30, 2009. Recent highligh...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
CRANBURY, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD ) today announced financial results for the second quarter 2009. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (GAAP), Amicus announced...Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results
SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today reported financial resul...Advanced Life Sciences to Host 2009 Second Quarter Financial Results Conference Call and Webcast
CHICAGO, Aug. 5 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), announced today that it will host a conference call and webcast discussing the Company's 2009 second quarter results on Tuesday, August 11, 2009 at 10:00 a.m. (EDT). Michael T. Fla...Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) today reported financial results for the second quarter ended June 30, 2009. Optimer reported a net loss for the second quarter of 2009 of $12.4 million, or $0.37 per share, which was in lin...AEterna Zentaris to Announce Second Quarter 2009 Financial and Operating Results on August 11, 2009
QUEBEC CITY, Aug. 5 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, will announce its second quarter 2009 financial and operating results before market open on Tuesday, August 11, 2009. The Co...NxStage Reports Second Quarter 2009 Financial Results
LAWRENCE, Mass., Aug. 5 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced net revenue for the second quarter of 2009 of $36.4 million, an increase of 15 percent when compared with revenue of $31.6 mi...SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today reported financial results for the second quarter ended June 30, 2009, and provided a corporate update. "Duri...
Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress
REDWOOD CITY, Calif., Aug 4 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today reported financial results and business progress for the quarter ended June 30, 2009. Total revenue increased to $36.6 million in the second quarter of 2009 compared w...LYNBROOK, N.Y., Aug. 4 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, announced today that the Company will host a conference call and live audio webcast at 4:30 p.m. ET on Wed...
NEW YORK, Aug. 4 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) will hold a conference call on Thursday, August 6, 2009 at 8:30 a.m. EDT to discuss the second quarter 2009 financial results and business outlook for the remainder of 2009. Ron Bentsur, Chief Executi...
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
SAN DIEGO, CA, August 4, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries,...Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
VENLO, The Netherlands, Aug. 4 /PRNewswire-FirstCall/ -- QIAGEN N.V. (Nasdaq: QGEN ) today announced the Webcast of its second quarter 2009 financial results call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, August 11, and will include remarks by Peer M. Schatz, President ...EMERYVILLE, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ) announced today that it will release financial results for the second quarter of fiscal year 2009 ended June 30, 2009 on Monday, August 10, 2009. The Company will conduct a conference call and web cast t...
OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results
BOTHELL, WA and VANCOUVER, Aug. 3 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals (NASDAQ: OGXI ) announced today that the Company will announce second quarter financial results on Thursday, August 6, 2009. OncoGenex will host a conference call and live webcast at 4:30 p.m. EDT that afternoon...Hoya Announces First Quarter Financial Results for FY2010
TOKYO, Japan, August 3 /PRNewswire-FirstCall/ -- HOYA Corporation today announced financial results for the first quarter ended June 30, 2009. Net sales were 94.9 billion yen for the quarter, a 27.0% decrease from 130.1 billion yen in the same period last year, and operating income was 9.2 bil...SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR ) will announce its financial results for the second quarter ended June 30, 2009 on Tuesday, August 4, 2009, after the close of U.S.-based financial markets. Howard Robin, president and chief execut...
ROCKVILLE, Md., July 31 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today announced that it will report its 2009 second quarter financial results in a press release to be issued after 8:00 a.m. Eastern Time on Friday, August 7, 2009. The Company will hold an investor conference ...
NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
SAN MATEO, Calif., July 31 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on Friday, August 7, 2009 at 9:00 a.m. ET (6:00 a.m. PT...CuraGen Reports Second Quarter 2009 Financial Results
BRANFORD, Conn., July 31 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN ) today reported its financial results for the second quarter of 2009 and announced that it had further reduced its outstanding convertible debt and reached an agreement in principle, expr...Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ), a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, today reported its financial results and program highligh...Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results
CHADDS FORD, Pa., July 30 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) today reported financial results for the second quarter of 2009, including a full quarter of results of Indevus Pharmaceuticals, Inc., which Endo acquired during the first quarter. Tota...Other TagsOther Contents
HospitalisesGravelyPanamaniansBulimictonedPartiesEthicProstituteJewishStemmedPotentialyDealingsguanfacineINTUNIV
(Date:5/21/2013)... whale entangled in fishing gear, scientists showed for the ... and swimming behavior. The monitoring revealed how fishing gear ... energy as they drag gear for months or years, ... scientists in this entanglement response suction-cupped a cellphone-size device ... right whale called Eg 3911. The Dtag, developed at ...
(Date:5/21/2013)... RICHLAND, Wash. A new analysis shows that the ... growth of enough algae to produce up to 25 ... United States, one-twelfth of the country,s yearly needs. , ... water resources that would be needed to grow significant ... The results were published in the May 7 issue ...
(Date:5/21/2013)... class of pharmaceuticals can both prevent and treat Alzheimer,s ... "TSPO ligands," are currently used for certain types of ... ligand in young adult mice when pathology was at ... was quite severe," said lead researcher Christian Pike of ... measures of pathology and improved behavior at both ages." ...
Breaking Biology News(10 mins):Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4Drugs found to both prevent and treat Alzheimer's disease in mice 2(Date:5/22/2013)... A new study shows there is a gender ... American young children one that does not appear ... United States, girls had higher levels of self-regulation than ... their behavior and impulses, follow directions, and persist on ... and college completion, in past studies by Oregon State ...
(Date:5/22/2013)... New York, New York (PRWEB) May 22, 2013 ... a metal-on-metal version of the DePuy Pinnacle Hip Replacement ... underway in Texas Federal Court, Bernstein Liebhard LLP reports. ... Court has directed DePuy Orthopaedics to produce monitoring reports ... government into the company’s medical device marketing practices. ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Twenty student-led ... next year participating in an intensive startup accelerator designed ... products or services and create local jobs as part ... Each year the Edson initiative offers approximately 20 student ... space, mentorship and training to launch their for-profit, more-than-profit ...
(Date:5/22/2013)... News) -- Over the next two decades, the cost ... to more than double, topping more than $180 billion ... factor driving the increase: an aging population. The report, ... Stroke Association, was published May 22 in the journal ... health care system," Dr. Bruce Ovbiagele, chairman of the ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Phelps Memorial ... the Westchester Lung Nodule Center for individuals who ... lung cancer care. Lung cancer is the deadliest form of ... people in the U.S. die from lung cancer than from ... all cancers, early detection increases survival rates. It is ...
Breaking Medicine News(10 mins):Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 4Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 5Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 6Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 7Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 8Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 9Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3[0] 'Boys will be boys' in US, but not in Asia[0] DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation[0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort[0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report[0] Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |